A detailed history of Neville Rodie & Shaw Inc transactions in Stryker Corp stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 2,866 shares of SYK stock, worth $1.12 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,866
Previous 2,866 -0.0%
Holding current value
$1.12 Million
Previous $975,000 6.15%
% of portfolio
0.08%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 04, 2023

SELL
$246.13 - $285.47 $65,716 - $76,220
-267 Reduced 8.52%
2,866 $818,000
Q4 2022

Jan 03, 2023

SELL
$205.51 - $253.93 $20,551 - $25,393
-100 Reduced 3.09%
3,133 $766,000
Q3 2022

Oct 04, 2022

SELL
$189.27 - $231.83 $28,390 - $34,774
-150 Reduced 4.43%
3,233 $655,000
Q1 2022

Apr 05, 2022

SELL
$245.33 - $277.77 $18,399 - $20,832
-75 Reduced 2.17%
3,383 $910,000
Q2 2021

Jul 06, 2021

BUY
$242.95 - $267.0 $840,121 - $923,286
3,458 New
3,458 $898,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $148B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.